Oncology trials in a shifting economical and geopolitical landscape

Webinar: Oncology trials in a shifting economical and geopolitical landscape

The pharmaceutical and biotech fields are spinning around, seeking to adapt to the current geopolitical situation and its impact on current and future oncology trials. Many trials have been shifted to other countries or regions while the complexity of managing risk increases.

Even though managing your studies in these economic times might seem challenging, all you need is thoughtful preparation and adaptation measures. Our experts will share practical tips and experience-based results on how you can do it too.

Planning your next oncology study?

Let’s talk how we can team up to conduct them effectively and ensure smooth processes.

What we will talk about?

Our experts will:

1. Give practical advice on how to plan your clinical study budget effectively;
2. Share the experience of successful geography shifts for ongoing clinical studies;
3. Discuss global tendencies in oncology clinical trials and how to adapt to them;
4. Talk about how to handle risk management.

    Duration: 50 minutes.

    Speakers:

    • Regina Auškalnienė, Chief Global Clinical Research Officer
    • Vladimir Mukovozchik, Head of Project Management
    • Oleg Kungurtsev, Head of Clinical Monitoring
    Regina Auškalnienė

    Regina Auškalnienė

    Chief Global Clinical Research Officer

    Other content that might interest you:

    No Results Found

    The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

    Running a Clinical Trial in Ukraine

    Running a Clinical Trial in Ukraine

    Despite the fact that Ukraine is the largest country in Eastern Europe with a large population of treatment-naïve patients, well organized public health care sector and significant number of medical sites accredited for clinical trial conduction, country has utilized only 15% of its current potential for hosting clinical trials. During 2017, the European Medicine Agency (EMA) gave positive recommendations on 94 new drug applications and 49 of them were tested in clinical trials in Ukraine. During the same year, the US FDA approved 151 new drugs, and 28 of them were also studied in Ukraine.

    read more
    What You Need to Know about Running a Clinical Trial in Russia?

    What You Need to Know about Running a Clinical Trial in Russia?

    Russia is a very perspective country for international clinical trial conduction. The first international clinical trial was set up in Russia about 20 years ago only, and from than country kept a great potential for market development. In 2018 health authorities (HAs) approved 653 clinical trials (CT) in Russian Federation, less in overall numbers compared to the same indicator from 2016 – 898 approved CTs. However, this decrease was observed across all types of clinical trials except for international multicentre clinical trials (IMCT).

    read more
    The CIS Region: Excellent Potential for Patient Recruitment but is there any Risk to Quality?

    The CIS Region: Excellent Potential for Patient Recruitment but is there any Risk to Quality?

    The number of clinical trials worldwide is increasing more than 10% each year due to the new diseases, further research for better health products and development of new drugs. Though, for a successful clinical trial, there is a major challenge – patient recruitment, which is essential and the most challenging factor due to the increasing number of new clinical trials. In order to achieve the required patient recruitment, sponsors are looking for different solutions.

    read more

    Big Enough To Cover  All Your Needs. Small Enough To Care.

    Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

    Clinical Research

    Regulatory Affairs

    Pharmacovigilance

    Medical Information